View Older Stories View More Recent Stories
-
BluMetric to Announce Q3 2026 Financial Results and Host Conference Call on August 27, 2026
-
CoTec Holdings Corp. Investment Magiron Demonstrates Excellent Reduction Pellet Quality in Latest Test Program
-
Clear Blue Technologies International to Report Q2 2026 Financial Results and Host Conference Call on Thursday, August 27th, 2026
-
Rocky Shore Outlines Major Exploration Advances with the Lucky 13 Gold Zone Discovery and Mosquito Target Horizon at the Gold Anchor Project
-
Zoe Financial Launches Framework to Help RIAs Decide What Functions to Outsource
-
XAU Resources Enters into Option Agreement to Acquire 100% Interest in Matthews Ridge Gold Project, Guyana
-
Awalé Defines New 4-Kilometre Gold Target at 100%-Owned Seydou Permit; Drilling Underway at the Fremen Discovery
-
American Tungsten Defines High-Grade Tungsten Mineral Resource in the United States at IMA Mine
-
H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)
-
H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG)
-
H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX)
-
H.C. Wainwright Reiterates Buy Rating on Bitdeer Technologies Group (BTDR)
-
H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
-
H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
-
Relay Therapeutics (RLAY) PT Raised to $29 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Cogent (COGT)
-
H.C. Wainwright Reiterates Buy Rating on Mirum Pharmaceuticals (MIRM)
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
Estee Lauder (EL) PT Raised to $90 at Canaccord
-
eToro Group (ETOR) PT Lowered to $53 at Canaccord
-
Ultragenyx Pharma (RARE) PT Raised to $83 at Canaccord
-
Ur-Energy Announces First Shipment of Uranium from Shirley Basin Mine, Wyoming
-
Okta, Inc (OKTA) PT Raised to $162 at Guggenheim
-
Target (TGT) PT Raised to $175 at Guggenheim
-
Veeva Systems (VEEV) PT Raised to $276 at Guggenheim
-
Guggenheim Reiterates Neutral Rating on CrowdStrike (CRWD)
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
RBC Capital Downgrades Coty Inc. (COTY) to Sector Perform
-
Lowe's (LOW) PT Lowered to $250 at Mizuho
-
Target (TGT) PT Raised to $150 at Mizuho
-
Mizuho Reiterates Outperform Rating on Cerebras Systems (CBRS)
-
Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
-
Oppenheimer Reiterates Outperform Rating on salesforce.com (CRM)
-
Vortex Metals hires advisory firm, appoints two former U.S. ambassadors
-
Daqo New Energy (DQ) Misses Q2 EPS by 67c
-
Qnity installs KLA wafer inspection system in Massachusetts fab
-
Parsons wins $350M Navy ISR contract for seabed-to-space systems
-
Trans Canada Gold wraps up phase 1 drilling at Harrison Lake project
-
Trans Canada Gold completes phase 1 drilling at Harrison Lake project
-
Heliostar Samples High Grade Antimony with Gold and Commences Drilling at Goldstrike Project, Utah
-
WELL Health Redeems $70 Million 5.50% Convertible Debentures
-
Trans Canada Gold Has Successfully Completed Phase 1- Drilling at the Harrison Lake District Scale Gold Project and Completes Updated Underground Mine Refurbishment
-
Vortex Metals Engages Global Frontier Advisors and Appoints Ambassador Roberta Jacobson and Ambassador James Story to Advisory Board
-
Gordon Haskett cuts TJX Companies rating to Accumulate
-
Needham Reiterates Hold Rating on Alight Solutions (ALIT)
-
Guggenheim Starts Freenome Inc. (FRNM) at Buy
-
Needham Reiterates Buy Rating on Bandwidth Inc. (BAND)
-
Greenbrier builds 50 railcars with low-emission steel for Alter Trading
-
Transocean wins $300M drillship contract with ONGC in India
